Molina Healthcare Inc (MOH) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
Molina Healthcare Inc (MOH) carries a Roarable Rating of C- (Hold) with 61/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
How MOH Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $45.43B | 13.1% | 1.7% | $472.0M | -$636.0M | 17.2% |
| FY 2024 | $40.65B | 15.3% | 4.2% | $1.18B | $544.0M | 48.9% |
| FY 2023 | $34.07B | 44% | 4.6% | $1.09B | $128.8M | 5% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring MOH)
- ✓Live walkthrough of MOH's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
MOH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +11.7% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on MOH today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for MOH. Explore sector supply chains on /butterfly.
MOH Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is Molina Healthcare Inc (MOH)?
In FY 2025 (10-K), MOH converted $45.4B of revenue into a 13.1% gross margin, 1.7% operating margin, and $0 in free cash flow (0% FCF margin).